Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes.

about

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes.

Item

http://www.wikidata.org/entity/Q41452593

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Potential benefit of (-)-epiga ...... lar complications in diabetes.

@en

type

Item

label

Potential benefit of (-)-epiga ...... lar complications in diabetes.

@en

prefLabel

Potential benefit of (-)-epiga ...... lar complications in diabetes.

@en

P1476

Potential benefit of (-)-epiga ...... lar complications in diabetes.

@en

P2093

C Zeng

http://www.w3.org/2001/XMLSchema#string

J Yang

http://www.w3.org/2001/XMLSchema#string

L Li

http://www.w3.org/2001/XMLSchema#string

L Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Green and black tea for the primary prevention of cardiovascular disease

Tea, flavonoids, and cardiovascular health: endothelial protection

Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis

Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals

Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress

Macrovascular Complications and Prevalence of Urgency Incontinence in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study.

Resveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro.

Epigallocatechin-3-gallate ameliorates hyperglycemia-induced embryonic vasculopathy and malformation by inhibition of Foxo3a activation.

Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.

Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice.

P304

e6511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/1414-431X20176511

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28832766

http://www.w3.org/2001/XMLSchema#string

P932

5561811

http://www.w3.org/2001/XMLSchema#string